| References |
|
|
Alizadeh AA,
Eisen MB,
Davis RE et al.
(2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
Nature
403: 503511.
|
|
|
Campbell LJ
(2005)
Cytogenetics of lymphomas.
Pathology
37: 493507.
|
|
|
Cheson BD
(2006)
Radioimmunotherapy of non-Hodgkin's lymphomas.
Current Drug Targets
7: 12931300.
|
|
|
Davies AJ,
Rosenwald A,
Wright G et al.
(2007)
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
British Journal of Haematology
136: 286293.
|
|
|
Fisher RI,
Gaynor ER,
Dahlberg S et al.
(1993)
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
New England Journal of Medicine
8(328): 10021006.
|
|
|
Harjunpaa A,
Taskinen M,
Nykter M et al.
(2006)
Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
British Journal of Haematology
135: 3342.
|
|
|
Harris NL,
Jaffe ES,
Diebold J et al.
(2000)
Lymphoma classification from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
Annals of Oncology
11(suppl. 1): 310.
|
|
|
Henrickson SE,
Hartmann EM,
Ott G and
Rosenwald A
(2007)
Gene expression profiling in malignant lymphomas.
Advances in Experimental Medicine and Biology
593: 134146.
|
|
|
Hummel M,
Bentink S,
Berger H et al.
(2006)
Molecular mechanisms in malignant lymphomas network project of the Deutsche Krebshilfe. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
New England Journal of Medicine
8(354): 24192430.
|
|
|
Hurvitz SA and
Timmerman JM
(2005)
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
Current Opinion in Oncology
17: 432440.
|
|
|
International Non-Hodgkin's Lymphoma Prognostic Factors Project
(1993)
A predictive model for aggressive non-Hodgkin's lymphoma.
New England Journal of Medicine
329: 987994.
|
|
|
Lieber MR,
Yu K and
Raghavan SC
(2006)
Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations.
DNA Repair (Amst)
5: 12341245.
|
|
|
Magrath I,
Adde M,
Shad A et al.
(1996)
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Journal of Clinical Oncology
14: 925934.
|
|
|
Magrath IT
(1981)
Lymphocyte differentiation: an essential basis for the comprehension of lymphoid neoplasia.
Journal of the National Cancer Institute
67: 501514.
|
|
|
Marcus R and
Hagenbeek A
(2007)
The therapeutic use of rituximab in non-Hodgkin's lymphoma.
European Journal of Haematology
67(suppl. January): 514.
|
|
|
Pasqualucci L,
Bereschenko O,
Niu H et al.
(2003)
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6.
Leukemia Lymphoma
44(suppl. 3): S5S12.
|
|
|
Reiter A,
Schrappe M,
Ludwig WD et al.
(2000)
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood
95: 416421.
|
|
|
Reiter A,
Schrappe M,
Tiemann M et al.
(1999)
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the BerlinFrankfurtMunster Group trial NHLBFM 90.
Blood
94: 32943306.
|
|
|
Schulz H,
Bohlius JF,
Trelle S et al.
(2007)
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.
Journal of the National Cancer Institute
99: 706714.
|
|
|
Sebban C,
Mounier N,
Brousse N et al.
(2006)
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Blood
15; 108(8): 25402544.
|
|
|
Shivakumar L and
Armitage JO
(2006)
Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma.
Clinical Lymphoma and Myeloma
6: 455457.
|
|
|
Tracey L,
Villuendas R,
Dotor AM et al.
(2003)
Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.
Blood
102: 10421050.
|
|
|
van Doorn R,
Zoutman WH,
Dijkman R et al.
(2005)
Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
Journal of Clinical Oncology
10; 23: 38863896.
|
| Further Reading |
|
|
Anderson JR,
Armitage JO and
Weisenburger DD
(1998)
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.
Annals of Oncology
9: 717720.
|
|
|
book
Armitage JO,
Cavalli F and
Longo DL (eds)
(1999)
Text Atlas of Lymphomas.
London:
Dunitz.
|
|
|
book
Canellos G,
Lister AT and
Young B (eds)
(2006)
The Lymphomas.
New York:
Saunders, Elsevier.
|
|
|
Cheson BD,
Horning SJ,
Coiffer B et al.
(1999)
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas.
Journal of Clinical Oncology
17: 1244.
|
|
|
book
Isaacson PG and Norton AJ
(1994)
Extranodal Lymphomas.
London:
Churchill Livingstone.
|
|
|
book
Jaffe ES,
Harris NL,
Stein H and
Vardiman JW
(2001)
Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.
Lyons, France:
IARC Publications.
|
|
|
book
Magrath I (ed.)
(1997)
The Non-Hodgkin's Lymphomas,
2nd edn.
London:
Arnold.
|
|
|
book
Mauch PM,
Armitage JO,
Coiffier B,
Dalla-Favera R and
Harris NL
(2004)
Non-Hodgkin's Lymphomas.
Philadelphia, PA:
Lippincott Williams and Wilkins.
|